Company intelligence / Profile preview
Corner Therapeutics
Watertown, Massachusetts, United Statescornertx.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Corner Therapeutics has developed a dendritic cell hyperactivation platform to create vaccines and immunotherapies that aim to provide robust, durable immunity against cancer and infectious diseases. The company raised $54 million in Series A funding in April 2024 to advance its preclinical pipeline toward first-in-human studies expected to begin in or after 2025. Its antigen agnostic approach aims for lifelong protection by teaching the immune system to engineer long-lived disease-fighting T cells. Grant funding from the Bill & Melinda Gates Foundation supports applications against major infectious diseases such as HIV, influenza, and COVID‑19. No clinical results have been reported yet.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Vaccines (therapeutic and preventative)Immunotherapies (T cell-based)Dendritic cell hyperactivation platform (hDC)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Bill & Melinda Gates Foundation (grant funding for infectious disease work)Unnamed prominent biopharma companies mentioned as partners but not specified by name.
Beyond the preview
Go deeper on Corner Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Corner Therapeutics.